Screener
Immunome IMNM Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Immunome’s reported figures.
The source filing: Immunome’s 10-Q, filed May 12, 2026. Open the filing →
- Filed
- May 12, 2026, 4:10 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-219425
FAQ
- What is Immunome's enterprise value?
- Immunome (IMNM) reported enterprise value of $1.9B in Q1 2026.
- How has Immunome's enterprise value changed year-over-year?
- Immunome's enterprise value increased by 470.3% year-over-year, from $332.33M to $1.9B.
- What is the long-term trend for Immunome's enterprise value?
- Over 4 years (2020 to 2025), Immunome's enterprise value has grown at a 116.8% compound annual growth rate (CAGR), from $77.87M to $1.72B.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.
Ask your AI about Immunome's enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude